Drug recall · November 22, 2017
Urin D/S Tablets Methenamine 81.6 mg recall
Why: Superpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Urin D/S Tablets Methenamine 81.6 mg, Sodium Biphosphate 40.8 mg, Phenyl Salicylate 36.2 mg, Methylene Blue 10.8 mg, Hyoscyamine Sulfate 0.12 mg, Rx Only, 100-count bottle, Manufactured For: Llorens Pharmaceutical Corp., International Division, Miami, FL 33166. NDC: 54859-701-10
- Lots / codes
Lots: 22811601, 22811602, Exp. 05/18; 202U1601 Exp. 11/18
- Quantity
- 19232 bottles
- Company
- Llorens Pharmaceutical Corp., Caguas, PR
- Distribution
- Puerto Rico
- Initiated
- September 5, 2017 · Voluntary: Firm initiated
- Classified
- November 15, 2017
- Reported
- November 22, 2017
- Ended
- April 3, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hyoscyamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.